Controlled-release CNP agonists with low NPR-C binding

US11311604B2 · kind B2 · utility

Assignee

• ASCENDIS PHARMA GROWTH DISORDERS A/S · DK

Inventors

• Harald Rau · Würzburg, DE
• Ulrich Hersel · Heidelberg, DE
• Kennett Sprogøe · Rudegård, DK
• Frank Faltinger · Heidelberg, DE
• Thomas Wegge · Heidelberg, DE
• Felix Cleemann · Mainz, DE

Key dates

• Filing date: Jan 5, 2017
• Grant date: Apr 26, 2022
• Expiry date: Oct 21, 2038

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a controlled-release CNP agonist having low NPR-C affinity; to pharmaceutical compositions comprising said controlled-release CNP agonist; their use; and to methods of treatment.